We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01355393
Recruitment Status : Active, not recruiting
First Posted : May 18, 2011
Last Update Posted : April 12, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Mary (Nora) Disis, University of Washington

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : November 2013
  Study Completion Date : No date given
  Certification or Request for Extension to Delay Results Submission: April 3, 2017